IR Information
Summary of Q&A Session for Management Presentation on May 30th 2025
FY2024 4Q Financial Results Presentation Summary of Q&A Session
Our Company‘s Position on the ISS Report
Presentation Material for Management Presentation on May 30th 2025
Notice of Convocation of the 166th Ordinary General Meeting of Shareholders Other Matters Subject to the Electronic Provision
Notice of Convocation of the 166th Ordinary General Meeting of Shareholders
News
New Building for the Manufacture of Diagnostic Reagents, Including Antigen Detection Kits, Is Now in Operation
This website uses cookies to ensure that you use this website comfortably. If you continue to browse this website, you will agree to the use of our cookies.